Navigation Links
New Clues to Stopping Colitis-Linked Cancer
Date:2/2/2009

2 immune system proteins could hold the key, study finds

MONDAY, Feb 2 (HealthDay News) -- Two immune system proteins may someday help doctors treat and prevent colitis-associated cancer (CAC), a new study suggests.

The Interleukin 6 (IL-6) cytokine, a protein released by cells in the immune system, plays a key role in tumor production of colitis-associated cancer, according to a study on mice done at the University of California, San Diego, School of Medicine. This work by IL-6 appears dependent on STAT3, a transcription factor that encourages cancer development, according to the findings published in the Feb. 3 online edition of Cancer Cell.

The findings suggest that targeting IL-6 and Stat3 mught be a way to stop or treat CAC, said lead researcher Michael Karin, a professor of pharmacology and pathology at the university and a member of its cancer center. For example, when researchers removed STAT3 from intestinal epithelial cells, the development of colitis-associated cancer stopped in the mice.

Inflammatory bowel disease, such as ulcerative colitis, puts people at a greater risk of developing colorectal cancer. Nearly half of people with the malignancy die from it.

The new study backs previous work by the San Diego researchers, who suspected that IL-6 helped foster chronic inflammation and the survival of malignant cells that helped promote cancer.

More information

The U.S. National Cancer Institute has more about colorectal cancer.



-- Kevin McKeever



SOURCE: University of California - San Diego, news release, Feb. 2, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
2. Online Epidemic Gives Clues to Bird Flu Spread
3. New knock-out gene model provides molecular clues to breast cancer
4. New clues to breast cancer development in high-risk women
5. Clues to Cell Death Could Fight Disease
6. Genes Give Clues to Newborn Lung Disease
7. Mouse Study Gives Clues to Colitis
8. VivoMetrics LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness
9. Protein Gives Clues to Pancreatic Cancer
10. A longer-living, healthier mouse that could hold clues to human aging
11. Clues to ensuring anti-HIV drugs are taken in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Clues to Stopping Colitis-Linked Cancer
(Date:5/3/2016)... ... May 03, 2016 , ... Dr. Poneh Ghasri, cosmetic ... treatments to both new and existing patients. Cosmetic dentistry allows patients to improve the ... have healthy smiles with some minor or more serious cosmetic flaws. These specials allow ...
(Date:5/3/2016)... ... May 03, 2016 , ... Celestix ... announced the new SecureAccess feature for its CelestixEdge solution. CelestixEdge is the ... enable organizations to get the DirectAccess user experience on unsupported DirectAccess clients ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... helps healthcare organizations, especially medium and small physician practices, to better grasp and ... unique step-by-step approach that guides practices on a well-defined, expert-created path to compliance. ...
(Date:5/2/2016)... ... May 03, 2016 , ... RNK Products, Inc. (RNK) ... software that enables the stethoscope stream to go over the video conferencing audio ... flagship PCP-USB stethoscope. , Remote auscultation involves two software elements on the PC: ...
(Date:5/2/2016)... ... May 02, 2016 , ... The ... Patient Experience Journal (PXJ), an international, open access, peer-reviewed journal focused on research ... issue representing international (non-US) based authors, the third volume of PXJ continues to ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... NEW YORK , May 2, 2016 ... the EMR (Electronic Medical Records) market in a recent ... International sales, vendor switches, Increased physician usage, a growing market ... trends were noted in Kalorama,s report EMR ... The report marks Kalorama,s seventh complete study of the ...
(Date:5/2/2016)...  Celsion Corporation (NASDAQ: CLSN ), an ... the first cohort of patients in its Phase ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... the first three patients dosed, GEN-1 plus standard ...
(Date:4/29/2016)... April 29, 2016 Acquisition ... Sciences, Product Development Capabilities in North ... Base . Indegene ( http://www.indegene.com ... the acquisition of Skura Corporation,s life science business. ... adaptive sales enablement technology for life science organizations ...
Breaking Medicine Technology: